

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 8.65230359 |
| 2 | establishment of viral latency (GO:0019043) | 7.70463298 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 7.57124763 |
| 4 | extracellular fibril organization (GO:0043206) | 6.73070140 |
| 5 | fibril organization (GO:0097435) | 5.64371174 |
| 6 | response to gravity (GO:0009629) | 5.32487754 |
| 7 | positive regulation of actin filament depolymerization (GO:0030836) | 5.26228185 |
| 8 | mitotic nuclear envelope reassembly (GO:0007084) | 5.23045602 |
| 9 | nuclear envelope reassembly (GO:0031468) | 5.23045602 |
| 10 | * detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.20744532 |
| 11 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 5.12429253 |
| 12 | DNA unwinding involved in DNA replication (GO:0006268) | 4.80999237 |
| 13 | endothelial tube morphogenesis (GO:0061154) | 4.78222575 |
| 14 | morphogenesis of an endothelium (GO:0003159) | 4.78222575 |
| 15 | regulation of metalloenzyme activity (GO:0048552) | 4.56399687 |
| 16 | muscle cell migration (GO:0014812) | 4.36336092 |
| 17 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.34419427 |
| 18 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.32196247 |
| 19 | * detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 4.22568870 |
| 20 | proteasome assembly (GO:0043248) | 4.14470236 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.12943440 |
| 22 | positive regulation of pseudopodium assembly (GO:0031274) | 4.12381115 |
| 23 | sequestering of actin monomers (GO:0042989) | 4.04622927 |
| 24 | actin filament depolymerization (GO:0030042) | 4.00655941 |
| 25 | barbed-end actin filament capping (GO:0051016) | 3.98193526 |
| 26 | response to interferon-beta (GO:0035456) | 3.93572113 |
| 27 | type B pancreatic cell proliferation (GO:0044342) | 3.85843323 |
| 28 | regulation of pseudopodium assembly (GO:0031272) | 3.69171015 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.68147542 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.68147542 |
| 31 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.62839928 |
| 32 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.61965888 |
| 33 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.61965888 |
| 34 | galactose catabolic process (GO:0019388) | 3.60637351 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.50311142 |
| 36 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.49805529 |
| 37 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.47358740 |
| 38 | heterochromatin organization (GO:0070828) | 3.43486294 |
| 39 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41873411 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.40943693 |
| 41 | pattern specification involved in kidney development (GO:0061004) | 3.33745791 |
| 42 | nucleoside transmembrane transport (GO:1901642) | 3.33355007 |
| 43 | membrane raft organization (GO:0031579) | 3.32608334 |
| 44 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30394942 |
| 45 | cellular copper ion homeostasis (GO:0006878) | 3.28832001 |
| 46 | positive regulation of protein complex disassembly (GO:0043243) | 3.25921573 |
| 47 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25227541 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.23349335 |
| 49 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.22914376 |
| 50 | negative regulation of ligase activity (GO:0051352) | 3.22914376 |
| 51 | cellular response to zinc ion (GO:0071294) | 3.22599585 |
| 52 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.22041917 |
| 53 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.15256359 |
| 54 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.14026817 |
| 55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.14026817 |
| 56 | regulation of mitochondrial translation (GO:0070129) | 3.09890928 |
| 57 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.09189611 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06574423 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06574423 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06574423 |
| 61 | retina homeostasis (GO:0001895) | 3.03897561 |
| 62 | cortical actin cytoskeleton organization (GO:0030866) | 3.01223381 |
| 63 | myoblast migration (GO:0051451) | 2.99359511 |
| 64 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.98715942 |
| 65 | endosome to melanosome transport (GO:0035646) | 2.98488644 |
| 66 | endosome to pigment granule transport (GO:0043485) | 2.98488644 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97399199 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.97399199 |
| 69 | galactose metabolic process (GO:0006012) | 2.97295522 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.95816683 |
| 71 | pyrimidine nucleoside salvage (GO:0043097) | 2.94299605 |
| 72 | pyrimidine-containing compound salvage (GO:0008655) | 2.94299605 |
| 73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.90848942 |
| 74 | GDP-mannose metabolic process (GO:0019673) | 2.88058103 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 2.87652452 |
| 76 | negative regulation of mitochondrion organization (GO:0010823) | 2.85960771 |
| 77 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.85664836 |
| 78 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.85257023 |
| 79 | fibrinolysis (GO:0042730) | 2.84243609 |
| 80 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81821271 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 2.81821271 |
| 82 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79498168 |
| 83 | glycolytic process (GO:0006096) | 2.79010754 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.78783725 |
| 85 | glomerular visceral epithelial cell development (GO:0072015) | 2.76315715 |
| 86 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.75784712 |
| 87 | virion assembly (GO:0019068) | 2.74174970 |
| 88 | response to copper ion (GO:0046688) | 2.74014105 |
| 89 | protein complex biogenesis (GO:0070271) | 2.73616844 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.73319948 |
| 91 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.73079603 |
| 92 | base-excision repair (GO:0006284) | 2.70051625 |
| 93 | ATP synthesis coupled proton transport (GO:0015986) | 2.68476990 |
| 94 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68476990 |
| 95 | response to interferon-alpha (GO:0035455) | 2.67512238 |
| 96 | cortical cytoskeleton organization (GO:0030865) | 2.67260856 |
| 97 | regulation of cell aging (GO:0090342) | 2.67181233 |
| 98 | heme biosynthetic process (GO:0006783) | 2.65344541 |
| 99 | AMP metabolic process (GO:0046033) | 2.64838682 |
| 100 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64724213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.91199068 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.86032458 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.54828407 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.05200029 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.03531575 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.79464708 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.73475925 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.55989320 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.54786465 |
| 10 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.53263447 |
| 11 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.44621160 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.43329560 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38114263 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.37327090 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.34880010 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32978342 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22336849 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15567727 |
| 19 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11817055 |
| 20 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07928084 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.07575182 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.05662124 |
| 23 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.02510540 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91034571 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89889870 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.85204001 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.83448059 |
| 28 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82818328 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81518234 |
| 30 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.81389967 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79476870 |
| 32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78948169 |
| 33 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.77353217 |
| 34 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75906150 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71642766 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71581151 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70359868 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69570313 |
| 39 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.64150224 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62218454 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61922621 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57641283 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56113508 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49546495 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47802396 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42976051 |
| 47 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42209771 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41656072 |
| 49 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38758208 |
| 50 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.38124247 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.37513956 |
| 52 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.37213521 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36174681 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34865401 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34600741 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34320115 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33492823 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31456604 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29240122 |
| 60 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26733563 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24492029 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23651416 |
| 63 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22786216 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22786216 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22321835 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21739379 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18677491 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17945841 |
| 69 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15534896 |
| 70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15484667 |
| 71 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15102387 |
| 72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14150801 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13235175 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12797946 |
| 75 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11817918 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10220234 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09881008 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08494712 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08385966 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08236446 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07738355 |
| 82 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07265025 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05815538 |
| 84 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05633072 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04285266 |
| 86 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04098887 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03450780 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03425691 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02889988 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02224648 |
| 91 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02178025 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01605102 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00842999 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00558955 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99818108 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99455380 |
| 97 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.98451297 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98017637 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97643644 |
| 100 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96934502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 4.93314560 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.44350028 |
| 3 | MP0010030_abnormal_orbit_morphology | 3.64321787 |
| 4 | MP0000751_myopathy | 3.51739072 |
| 5 | MP0005257_abnormal_intraocular_pressure | 3.28702537 |
| 6 | MP0004510_myositis | 3.19578920 |
| 7 | MP0000750_abnormal_muscle_regeneration | 3.10611411 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.85035658 |
| 9 | MP0005165_increased_susceptibility_to | 2.82645721 |
| 10 | MP0003075_altered_response_to | 2.72631219 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.64581065 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.62603321 |
| 13 | MP0001542_abnormal_bone_strength | 2.59621351 |
| 14 | MP0000749_muscle_degeneration | 2.57989613 |
| 15 | MP0004272_abnormal_basement_membrane | 2.47058970 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.41643985 |
| 17 | MP0003315_abnormal_perineum_morphology | 2.41620956 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.22593512 |
| 19 | MP0005330_cardiomyopathy | 2.15260295 |
| 20 | MP0000343_altered_response_to | 2.09099084 |
| 21 | MP0009840_abnormal_foam_cell | 2.03673802 |
| 22 | MP0005367_renal/urinary_system_phenotyp | 1.89995346 |
| 23 | MP0000516_abnormal_urinary_system | 1.89995346 |
| 24 | MP0000858_altered_metastatic_potential | 1.82488826 |
| 25 | MP0001853_heart_inflammation | 1.77437129 |
| 26 | MP0001299_abnormal_eye_distance/ | 1.70348582 |
| 27 | MP0005360_urolithiasis | 1.65685492 |
| 28 | MP0006054_spinal_hemorrhage | 1.61308429 |
| 29 | MP0003786_premature_aging | 1.61167257 |
| 30 | MP0008260_abnormal_autophagy | 1.59916988 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.59813450 |
| 32 | MP0003329_amyloid_beta_deposits | 1.57281125 |
| 33 | MP0003186_abnormal_redox_activity | 1.52489989 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.48972048 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.46928081 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.45647623 |
| 37 | MP0003436_decreased_susceptibility_to | 1.44498267 |
| 38 | MP0005670_abnormal_white_adipose | 1.42046484 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.34027895 |
| 40 | MP0004147_increased_porphyrin_level | 1.32576307 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.28064172 |
| 42 | MP0005166_decreased_susceptibility_to | 1.27617832 |
| 43 | MP0009697_abnormal_copulation | 1.25494923 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.21453214 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.18613791 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.16651362 |
| 47 | MP0002177_abnormal_outer_ear | 1.16379958 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.15686729 |
| 49 | MP0002060_abnormal_skin_morphology | 1.14345032 |
| 50 | MP0001243_abnormal_dermal_layer | 1.13881812 |
| 51 | MP0003279_aneurysm | 1.12935237 |
| 52 | MP0005197_abnormal_uvea_morphology | 1.12427480 |
| 53 | MP0000647_abnormal_sebaceous_gland | 1.12221242 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.07481909 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05847642 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.04316274 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.04262913 |
| 58 | MP0005083_abnormal_biliary_tract | 1.02923893 |
| 59 | MP0003718_maternal_effect | 0.99238574 |
| 60 | MP0010368_abnormal_lymphatic_system | 0.98306196 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.98138601 |
| 62 | MP0003638_abnormal_response/metabolism_ | 0.96304084 |
| 63 | MP0002106_abnormal_muscle_physiology | 0.90229940 |
| 64 | MP0000358_abnormal_cell_content/ | 0.88538844 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 0.87503533 |
| 66 | MP0005164_abnormal_response_to | 0.85963264 |
| 67 | MP0001905_abnormal_dopamine_level | 0.85789584 |
| 68 | MP0009764_decreased_sensitivity_to | 0.85685342 |
| 69 | MP0004957_abnormal_blastocyst_morpholog | 0.83543349 |
| 70 | MP0000762_abnormal_tongue_morphology | 0.83452088 |
| 71 | MP0003077_abnormal_cell_cycle | 0.82241653 |
| 72 | MP0005501_abnormal_skin_physiology | 0.80968784 |
| 73 | MP0000747_muscle_weakness | 0.78279853 |
| 74 | MP0003693_abnormal_embryo_hatching | 0.76332877 |
| 75 | MP0000604_amyloidosis | 0.75950521 |
| 76 | MP0005451_abnormal_body_composition | 0.75401653 |
| 77 | MP0008932_abnormal_embryonic_tissue | 0.75206319 |
| 78 | MP0009053_abnormal_anal_canal | 0.73420706 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.73387558 |
| 80 | MP0000249_abnormal_blood_vessel | 0.72947035 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.71686127 |
| 82 | MP0002796_impaired_skin_barrier | 0.71576503 |
| 83 | MP0000534_abnormal_ureter_morphology | 0.70676971 |
| 84 | MP0009278_abnormal_bone_marrow | 0.70150657 |
| 85 | MP0003121_genomic_imprinting | 0.68944152 |
| 86 | MP0005023_abnormal_wound_healing | 0.66840754 |
| 87 | MP0005390_skeleton_phenotype | 0.66652700 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.66221739 |
| 89 | MP0002006_tumorigenesis | 0.65378533 |
| 90 | MP0003091_abnormal_cell_migration | 0.65217368 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.62915442 |
| 92 | MP0008058_abnormal_DNA_repair | 0.60455156 |
| 93 | MP0008469_abnormal_protein_level | 0.59010045 |
| 94 | MP0005395_other_phenotype | 0.58593197 |
| 95 | MP0005266_abnormal_metabolism | 0.57683063 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.56326750 |
| 97 | MP0000613_abnormal_salivary_gland | 0.55449998 |
| 98 | MP0010771_integument_phenotype | 0.54038266 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.53866692 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.53612671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amyloidosis (HP:0011034) | 6.07699565 |
| 2 | Glucose intolerance (HP:0000833) | 4.42236052 |
| 3 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.27817501 |
| 4 | Adrenal hypoplasia (HP:0000835) | 4.02263627 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.83335463 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.77132004 |
| 7 | Delayed CNS myelination (HP:0002188) | 3.59504282 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 3.47623811 |
| 9 | Hepatic necrosis (HP:0002605) | 3.43333742 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.43119721 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.32053178 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 3.32053178 |
| 13 | Microglossia (HP:0000171) | 3.26343948 |
| 14 | Upper limb muscle weakness (HP:0003484) | 3.25135529 |
| 15 | Axonal loss (HP:0003447) | 3.22651678 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.20320607 |
| 17 | Cholecystitis (HP:0001082) | 3.20320607 |
| 18 | Increased serum pyruvate (HP:0003542) | 3.19502651 |
| 19 | Insulin resistance (HP:0000855) | 3.16151337 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10702775 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.10477220 |
| 22 | Vascular calcification (HP:0004934) | 3.08946090 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.99848695 |
| 24 | Abnormality of glycolysis (HP:0004366) | 2.98865601 |
| 25 | Abnormal glucose tolerance (HP:0001952) | 2.95801997 |
| 26 | Joint hemorrhage (HP:0005261) | 2.78776900 |
| 27 | Late onset (HP:0003584) | 2.78623748 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77794615 |
| 29 | Entropion (HP:0000621) | 2.77731603 |
| 30 | Rough bone trabeculation (HP:0100670) | 2.77437226 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 2.73614514 |
| 32 | Limb-girdle muscle atrophy (HP:0003797) | 2.72869923 |
| 33 | Increased CSF lactate (HP:0002490) | 2.71513789 |
| 34 | Short nail (HP:0001799) | 2.71216598 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.68777917 |
| 36 | Hand muscle atrophy (HP:0009130) | 2.66166141 |
| 37 | Reduced antithrombin III activity (HP:0001976) | 2.66092367 |
| 38 | Flat capital femoral epiphysis (HP:0003370) | 2.62855153 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 2.59870027 |
| 40 | Exercise intolerance (HP:0003546) | 2.59820069 |
| 41 | Pelvic girdle muscle weakness (HP:0003749) | 2.54864166 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.54021422 |
| 43 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.53342348 |
| 44 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.53342348 |
| 45 | Acute encephalopathy (HP:0006846) | 2.51883933 |
| 46 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.47134660 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.46719818 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.46469767 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.44347996 |
| 50 | Bifid uvula (HP:0000193) | 2.42757650 |
| 51 | Exertional dyspnea (HP:0002875) | 2.42049204 |
| 52 | Prolonged neonatal jaundice (HP:0006579) | 2.41504304 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41072674 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.35535808 |
| 55 | J-shaped sella turcica (HP:0002680) | 2.33908377 |
| 56 | Sparse eyelashes (HP:0000653) | 2.33631281 |
| 57 | Abnormal protein glycosylation (HP:0012346) | 2.33409899 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.33409899 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33409899 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33409899 |
| 61 | Secondary amenorrhea (HP:0000869) | 2.31084969 |
| 62 | Opisthotonus (HP:0002179) | 2.30208359 |
| 63 | Atrophic scars (HP:0001075) | 2.28891427 |
| 64 | Increased intramyocellular lipid droplets (HP:0012240) | 2.28200992 |
| 65 | Difficulty climbing stairs (HP:0003551) | 2.24661842 |
| 66 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.21436434 |
| 67 | Distal upper limb amyotrophy (HP:0007149) | 2.19369593 |
| 68 | Upper limb amyotrophy (HP:0009129) | 2.19369593 |
| 69 | Abnormality of the sella turcica (HP:0002679) | 2.18617665 |
| 70 | Polygenic inheritance (HP:0010982) | 2.17651634 |
| 71 | Increased connective tissue (HP:0009025) | 2.15935359 |
| 72 | Short clavicles (HP:0000894) | 2.15217042 |
| 73 | Testicular atrophy (HP:0000029) | 2.14231010 |
| 74 | Emotional lability (HP:0000712) | 2.13223371 |
| 75 | Severe muscular hypotonia (HP:0006829) | 2.13169445 |
| 76 | Fatigue (HP:0012378) | 2.10270300 |
| 77 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.09826101 |
| 78 | Myocardial infarction (HP:0001658) | 2.07770207 |
| 79 | Abnormal spermatogenesis (HP:0008669) | 2.07328157 |
| 80 | Down-sloping shoulders (HP:0200021) | 2.07319811 |
| 81 | Muscle stiffness (HP:0003552) | 2.06668972 |
| 82 | Increased serum lactate (HP:0002151) | 2.06239343 |
| 83 | Lactic acidosis (HP:0003128) | 2.05884197 |
| 84 | Acanthosis nigricans (HP:0000956) | 2.04240695 |
| 85 | Dysostosis multiplex (HP:0000943) | 1.99808339 |
| 86 | Hypoplastic pelvis (HP:0008839) | 1.99322924 |
| 87 | Abnormal platelet function (HP:0011869) | 1.97560156 |
| 88 | Impaired platelet aggregation (HP:0003540) | 1.97560156 |
| 89 | Joint stiffness (HP:0001387) | 1.94671270 |
| 90 | Congenital, generalized hypertrichosis (HP:0004540) | 1.93280773 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 1.92540175 |
| 92 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91526645 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.91082839 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 1.90718447 |
| 95 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90038003 |
| 96 | Respiratory failure (HP:0002878) | 1.89562818 |
| 97 | Onycholysis (HP:0001806) | 1.89478483 |
| 98 | Bradycardia (HP:0001662) | 1.88880985 |
| 99 | Neck muscle weakness (HP:0000467) | 1.88787094 |
| 100 | Dysautonomia (HP:0002459) | 1.87369534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.75302067 |
| 2 | TESK1 | 5.47156164 |
| 3 | TESK2 | 5.36972806 |
| 4 | NME2 | 4.46534521 |
| 5 | LIMK1 | 4.28970490 |
| 6 | EPHA2 | 3.56739758 |
| 7 | LMTK2 | 3.05920970 |
| 8 | ARAF | 2.93369633 |
| 9 | PIM2 | 2.49114443 |
| 10 | BUB1 | 2.48447164 |
| 11 | MAP2K7 | 2.15332680 |
| 12 | BCKDK | 2.11917842 |
| 13 | ERN1 | 2.02244237 |
| 14 | DAPK1 | 2.01772139 |
| 15 | IRAK3 | 1.78380471 |
| 16 | TAOK2 | 1.66368076 |
| 17 | PHKG1 | 1.56232429 |
| 18 | PHKG2 | 1.56232429 |
| 19 | STK10 | 1.48357827 |
| 20 | MOS | 1.43492543 |
| 21 | VRK1 | 1.42006237 |
| 22 | ABL2 | 1.32901270 |
| 23 | KDR | 1.31798827 |
| 24 | TAF1 | 1.24041563 |
| 25 | PAK4 | 1.23532512 |
| 26 | HIPK2 | 1.18199716 |
| 27 | MAP3K12 | 1.12685996 |
| 28 | CSNK1G3 | 1.10748825 |
| 29 | MAPKAPK3 | 1.10479950 |
| 30 | MAP3K11 | 1.08720077 |
| 31 | SRPK1 | 1.08092736 |
| 32 | CSNK1A1L | 1.01729929 |
| 33 | ERBB4 | 0.96459867 |
| 34 | GRK5 | 0.94576524 |
| 35 | MST1R | 0.91154903 |
| 36 | PTK2 | 0.86864781 |
| 37 | NEK1 | 0.85922778 |
| 38 | EPHB2 | 0.84726530 |
| 39 | STK16 | 0.84692720 |
| 40 | AURKA | 0.84672498 |
| 41 | TBK1 | 0.82777121 |
| 42 | PTK2B | 0.81922113 |
| 43 | MST4 | 0.79589611 |
| 44 | BRAF | 0.77903594 |
| 45 | CDK8 | 0.77553276 |
| 46 | BRSK1 | 0.77256626 |
| 47 | CSNK1G1 | 0.77146852 |
| 48 | CSNK1G2 | 0.76867046 |
| 49 | CCNB1 | 0.73837597 |
| 50 | SMG1 | 0.73433725 |
| 51 | DAPK3 | 0.72635287 |
| 52 | ILK | 0.70776619 |
| 53 | NUAK1 | 0.69716819 |
| 54 | MAP3K3 | 0.69195850 |
| 55 | PAK1 | 0.68495790 |
| 56 | MYLK | 0.67972727 |
| 57 | TGFBR2 | 0.66737326 |
| 58 | PRPF4B | 0.66569231 |
| 59 | DAPK2 | 0.65507289 |
| 60 | GRK7 | 0.61768169 |
| 61 | SCYL2 | 0.59657742 |
| 62 | CDK19 | 0.57349962 |
| 63 | EPHB1 | 0.57160440 |
| 64 | BMX | 0.54341072 |
| 65 | LRRK2 | 0.54104980 |
| 66 | CDK7 | 0.51356455 |
| 67 | RAF1 | 0.48703574 |
| 68 | CDK14 | 0.46012811 |
| 69 | PRKCI | 0.44645608 |
| 70 | PDK2 | 0.41693630 |
| 71 | EIF2AK2 | 0.39196200 |
| 72 | CDK15 | 0.38214204 |
| 73 | CDK11A | 0.37720555 |
| 74 | CDK18 | 0.37374942 |
| 75 | PLK1 | 0.34656414 |
| 76 | AURKB | 0.33565500 |
| 77 | ADRBK1 | 0.33011625 |
| 78 | MAPKAPK2 | 0.32832890 |
| 79 | CAMKK2 | 0.32812991 |
| 80 | CDC7 | 0.31691184 |
| 81 | MAPKAPK5 | 0.31653270 |
| 82 | GSK3A | 0.31531421 |
| 83 | IKBKE | 0.29168249 |
| 84 | PLK3 | 0.27591883 |
| 85 | CSNK2A2 | 0.26138986 |
| 86 | RPS6KA5 | 0.24750480 |
| 87 | EPHA4 | 0.21905514 |
| 88 | MAP3K8 | 0.21057169 |
| 89 | CAMK2G | 0.20879365 |
| 90 | TLK1 | 0.20084249 |
| 91 | PTK6 | 0.18764251 |
| 92 | MET | 0.17315237 |
| 93 | PRKACB | 0.17303985 |
| 94 | FER | 0.15965983 |
| 95 | PRKD1 | 0.14272542 |
| 96 | MAP3K1 | 0.12794731 |
| 97 | MAP3K5 | 0.12059042 |
| 98 | MAP2K3 | 0.10919035 |
| 99 | ROCK1 | 0.10268964 |
| 100 | ICK | 0.09924680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.98597214 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.44414828 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.18316076 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.71982667 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.68451149 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.62897481 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.60915731 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.53884704 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.52943249 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.40981657 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.39599204 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.28097468 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21524388 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.06705382 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.99556199 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.99170951 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.96870046 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92874043 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.92008386 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.88159350 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.84834247 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80294511 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.76112327 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.74609962 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.68884756 |
| 26 | * Salivary secretion_Homo sapiens_hsa04970 | 1.66403427 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.61876167 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56788181 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.46598893 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46017226 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42690216 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41881739 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34881043 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34184270 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32583633 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.31947162 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31472228 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29904674 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23067388 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.04781346 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04743402 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03212178 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97902558 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97295727 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95972268 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.88870542 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85620355 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79353308 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.79228795 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77671960 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76840464 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75203177 |
| 53 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74253496 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.74056941 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67519977 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64337776 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64296154 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63222853 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61206835 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.58187746 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.57322609 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53349501 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53036508 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52906890 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51524237 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.50172577 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48652230 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47910271 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.46792536 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.46724054 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46087368 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.43571855 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42176806 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.41394613 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40713247 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39761117 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38631843 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38571168 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33331841 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32123242 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31882967 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29844504 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27141320 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.26585688 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25435007 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23136186 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.20872605 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20043142 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19489339 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.18036596 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.17898080 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.17848774 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17842054 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.15984239 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15908598 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15518430 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.15335310 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15134632 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14981889 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.14872456 |

